A trial of Ampion(TM) in patients with nasal inflammation (rhinitis).
Phase of Trial: Phase II
Latest Information Update: 28 Dec 2011
At a glance
- Drugs DMI 9523 (Primary)
- Indications Rhinitis
- Focus Therapeutic Use
- 28 Dec 2011 New trial record
- 10 Nov 2011 Results released in an Ampio Pharmaceuticals media release.